Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization - Verteporfin in photodynamic therapy report 2

被引：52
|
作者：
Bressler, NM
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2002年 / 133卷 / 01期
关键词：
D O I：
10.1016/S0002-9394(01)01237-5
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [21] 12-month retrospective study and review of photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in age-related macular degeneration
    Incorvaia, Carlo
    Campa, Claudio
    Parmeggiani, Francesco
    Menzione, Massimo
    D'Angelo, Sergio
    Della Corte, Michele
    Rinaldi, Michele
    Romano, Mary
    Dell'Omo, Roberto
    Costagliola, Ciro
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (02): : 289 - 297
  • [22] Photodynamic therapy of subfoveal choroidal neovascularization (CNV) in age-related macular degeneration (AMD) using verteporfin: Safety results from an expanded access study, the verteporfin in age-related macular degeneration (VAM) trial.
    Ho, AC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S305 - S305
  • [23] Photodynamic therapy or macular translocation for subfoveal choroidal neovascularization in age-related macular degeneration
    Pawlak, D
    Glacet-Bernard, A
    Roquet, W
    Coscas, G
    Soubrane, G
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U989 - U989
  • [24] Photodynamic therapy with verteporfin of predominantly classic subfoveal choroidal neovascularization secondary to age-related macular degeneration: evaluation of the efficacy and safety in the VIT study.
    Maestroni, L
    Ottochian, M
    Staurenghi, G
    Orzalesi, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S439 - S439
  • [25] Twelve month clinical outcomes following treatment of subfoveal choroidal neovascularization in age-related macular degeneration using photodynamic therapy with verteporfin (Visudyne)
    Potter, MJ
    Szabo, SM
    Hao, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U413 - U413
  • [26] Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration -: Results of retreatments in a phase 1 and 2 study
    Schmidt-Erfurth, U
    Miller, JW
    Sickenberg, M
    Laqua, H
    Barbazetto, I
    Gragoudas, ES
    Zografos, L
    Piguet, B
    Pournaras, CJ
    Donati, G
    Lane, AM
    Birngruber, R
    van den Berg, H
    Strong, HA
    Manjuris, U
    Gray, T
    Fsadni, M
    Bressler, NM
    ARCHIVES OF OPHTHALMOLOGY, 1999, 117 (09) : 1177 - 1187
  • [27] Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration
    Isola, V
    Pece, A
    Brancato, R
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2004, 24 (04): : 618 - 620
  • [28] Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration
    Costa, RA
    Farah, ME
    Cardillo, JA
    Belfort, R
    CURRENT EYE RESEARCH, 2001, 23 (04) : 271 - 275
  • [29] Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): Results of the Japanese AMD Trial (JAT) extension
    Tano, Yasuo
    Bressler, Neil M.
    Ishibashi, Tatsuro
    Ohji, Masahito
    Shiraga, Fumio
    Takahashi, Kanji
    Weisberger, Annemarie
    Yuzawa, Mitsuko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2008, 52 (02) : 99 - 107
  • [30] Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): Results of the Japanese AMD Trial (JAT) extension
    Masahito Ohji
    Japanese Journal of Ophthalmology, 2008, 52 : 99 - 107
12345